Double-blind, placebo-controlled crossov
โ
Strom, Charles M. ;Brusca, Rita M. ;Pizzi, William J.
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 675 KB
## Abstract We conducted a randomized, doubleโblind, placeboโcontrolled crossover study of folinic acid therapy (dlโLeucovorinยฎ, 15 mg/day) or placebo for males with Fragile X (fra(x)) syndrome. Twentyโone patients were enrolled in the study. The treatment periods were 3 months in length. Patients